T1	Participants 133 165	African American substance users
T2	Participants 273 313	African American and White cocaine users
T3	Participants 458 575	African American (n = 444) and White (n = 403) cocaine abusers participating in one of six randomized clinical trials
T4	Participants 615 711	African American and White patients who initiated treatment with a cocaine-negative urine sample
T5	Participants 952 990	patients who began treatment abstinent
T6	Participants 992 1049	Whites who began treatment with a cocaine positive sample
T7	Participants 1173 1245	African Americans who initiated treatment with a cocaine positive sample
T8	Participants 1576 1644	African American patients who are using cocaine upon treatment entry
